Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -2,00k | 22,00k | Vente | 11,00 | 51,35k | -3,75% |
| 2026-04-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -1,82k | 12,94k | Vente | 7,12 | 53,35k | -3,29% |
| 2026-04-01 | Mr. Christopher J. ZegarelliCFO | -2,43k | 17,28k | Vente | 7,11 | 27,31k | -8,17% |
| 2025-11-17 | Mr. Iliya I. PesicDirector | -400,00k | 772,80k | Vente | 1,93 - 1,94 | 5,35M | -6,96% |
| 2025-06-26 | Ms. Katherine S. Ngai-PesicChairman of the Board | -950,00k | 2,02M | Vente | 2,00 - 2,26 | 12,93M | -6,84% |
| 2025-12-04 | Ms. Katherine S. Ngai-PesicChairman of the Board | -300,00k | 597,00k | Vente | 1,99 | 3,60M | -7,69% |
| 2026-03-17 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -1,50k | 7,51k | Vente | 5,00 | 2,65k | -36,11% |
| 2026-01-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -1,40k | 5,68k | Sale to Issuer | 4,05 | 2,01k | -41,06% |
| 2025-12-11 | Mr. Anthony K. K. NgaiIndependent Director | 1 000,00 | 4,23k | Achat | 4,23 | 60,53k | 1,68% |
| 2025-12-10 | Ms. Katherine S. Ngai-PesicChairman of the Board | 25,00k | 103,31k | Achat | 4,13 | 14,18M | 0,18% |
| 2025-12-09 | Dr. Walden C. RhinesCEO & Director | 13,10k | 52,50k | Achat | 4,01 | 74,67k | 21,28% |
| 2025-12-09 | Ms. Katherine S. Ngai-PesicChairman of the Board | -170,00k | 0,00 | Other Disposition | - | 14,16M | -1,19% |
| 2025-12-08 | Mr. Christopher J. ZegarelliCFO | 10,00k | 37,95k | Achat | 3,80 | 23,49k | 74,11% |
| 2025-11-18 | Mr. Anthony K. K. NgaiIndependent Director | 10,00k | 42,56k | Achat | 4,26 | 59,53k | 20,19% |
| 2025-11-19 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -8,30k | 35,28k | Vente | 4,25 | 12,00 | -99,86% |
| 2025-11-18 | Dr. Walden C. RhinesCEO & Director | 29,00k | 118,17k | Achat | 4,07 | 61,57k | 89,04% |
| 2025-11-17 | Mr. Christopher J. ZegarelliCFO | 5,00k | 19,55k | Achat | 3,91 | 13,49k | 58,87% |
| 2025-11-17 | Dr. Walden C. RhinesCEO & Director | 11,27k | 43,98k | Achat | 3,90 | 32,57k | 52,93% |
| 2025-09-15 | Mr. Christopher J. ZegarelliCFO | 5,10k | 25,65k | Achat | 5,03 | 8,49k | 150,31% |
| 2025-10-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -2,51k | 13,65k | Sale to Issuer | 5,44 | 8,31k | -23,19% |
| 2025-09-08 | Mr. Anthony K. K. NgaiIndependent Director | 11,70k | 61,79k | Achat | 5,16 - 5,34 | 49,53k | 30,93% |
| 2025-08-13 | Dr. Babak Alizadeh TaheriInitié | -9,16k | 42,57k | Sale to Issuer | 4,65 | 773,16k | -1,17% |
| 2025-06-20 | Ms. Katherine S. Ngai-PesicChairman of the Board | -28,47k | 0,00 | Other Disposition | - | 14,33M | -0,20% |
| 2025-07-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -788,00 | 3,94k | Sale to Issuer | 5,00 | 3,81k | -17,15% |
| 2025-07-01 | Dr. Eric GuichardSenior VP & GM of TCAD Division | -1,57k | 7,85k | Sale to Issuer | 5,00 | 101,81k | -1,52% |
| 2025-07-01 | Dr. Babak Alizadeh TaheriInitié | -8,27k | 41,35k | Sale to Issuer | 5,00 | 782,31k | -1,05% |
| 2025-06-10 | Ms. Katherine S. Ngai-PesicChairman of the Board | -5,76k | 28,85k | Vente | 5,01 | 3,90M | -0,15% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.